6 employees
ChrysalisBioTherapeutics, Inc. is a privately held biopharmaceutical company.
2009
$588K
from 1 investors over 1 rounds
Chrysalis BioTherapeutics, Inc. raised $588K on August 11, 2020
Investors: National Institute of Allergy and Infectious Diseases (NIAID)